Odefsey Tablet
Product Images NDC 61958-2101

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Odefsey (NDC 61958-2101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gilead Sciences, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Odefsey 01)

FDA Label Image

Chemical Structure (Odefsey 02)

FDA Label Image

Chemical Structure (Odefsey 03)

FDA Label Image

Odefsey-04.jpg (Odefsey 04)

Odefsey tablets are a medication composed of rilpivirine and tenofovir alafenamide, used to treat HIV. The tablets come in a container with 30 tablets and are equivalent to 275 mg of rilpivirine and 25 mg of tenofovir alafenamide. They should be stored below 30°C and kept tightly closed in the original container, out of reach of children. The recommended dosage and administration can be found in the insert, and pharmacists should not cover the ALERT box with a pharmacy label. The product is manufactured by Gilead Sciences in Foster City, CA, and made in Canada.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.